Healthcare & Life Sciences

Nova Anchora

Nova Anchora is a Healthcare & Life Sciences startup based in Finland, most recent round Pre-Seed, 1 tracked investor.

activepre-seed
pre-seed
Stage
1
Investors

About Nova Anchora

Based in Finland, Nova Anchora is a startup. Its most recent tracked round is Pre-Seed. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.

Nova Anchora is developing NvA-021, a corrective topical biologic therapy gel for Dystrophic Epidermolysis Bullosa (DEB), a rare genetic skin disease. The gel delivers a genetically corrected version of collagen VII to improve wound healing in patients.

Explore Nova Anchora's full profile on Brouky

Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.

Other Startups in Finland